Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations.

I Tsiligianni, J Kocks, N Tzanakis… - … journal: journal of the …, 2011 - europepmc.org
Background A major goal in the management of chronic obstructive pulmonary disease
(COPD) is to ensure that the burden of the disease for patients with COPD is limited and that …

Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art

ARC Patel, JR Hurst - Expert review of respiratory medicine, 2011 - Taylor & Francis
Extrapulmonary comorbidities are common and significant in chronic obstructive pulmonary
disease (COPD), often contributing to symptoms, exacerbations, hospital admissions and …

Azithromycin for prevention of exacerbations of COPD

RK Albert, J Connett, WC Bailey… - … England Journal of …, 2011 - Mass Medical Soc
Background Acute exacerbations adversely affect patients with chronic obstructive
pulmonary disease (COPD). Macrolide antibiotics benefit patients with a variety of …

The clinical features of the overlap between COPD and asthma

M Hardin, EK Silverman, RG Barr, NN Hansel… - Respiratory …, 2011 - Springer
Background The coexistence of COPD and asthma is widely recognized but has not been
well described. This study characterizes clinical features, spirometry, and chest CT scans of …

Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation

P Mallia, SD Message, V Gielen, M Contoli… - American journal of …, 2011 - atsjournals.org
Rationale: Respiratory virus infections are associated with chronic obstructive pulmonary
disease (COPD) exacerbations, but a causative relationship has not been proven. Studies of …

The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study

V Kim, MLK Han, GB Vance, BJ Make, JD Newell… - Chest, 2011 - Elsevier
Background Chronic bronchitis (CB) in patients with COPD is associated with an
accelerated lung function decline and an increased risk of respiratory infections. Despite its …

Reduction of exacerbations by the PDE4 inhibitor roflumilast-the importance of defining different subsets of patients with COPD

SI Rennard, PMA Calverley, UM Goehring… - Respiratory …, 2011 - Springer
Background As chronic obstructive pulmonary disease (COPD) is a heterogeneous disease
it is unlikely that all patients will benefit equally from a given therapy. Roflumilast, an oral …

Outdoor air pollution and respiratory health in patients with COPD

JL Peacock, HR Anderson, SA Bremner, L Marston… - Thorax, 2011 - thorax.bmj.com
Objectives Time series studies have shown adverse effects of outdoor air pollution on
mortality and hospital admissions in patients with chronic obstructive pulmonary disease …

[HTML][HTML] Health-related quality of life in patients by COPD severity within primary care in Europe

PW Jones, G Brusselle, RW Dal Negro, M Ferrer… - Respiratory …, 2011 - Elsevier
Pan-European data on health-related quality of life (HRQL) in chronic obstructive pulmonary
disease (COPD) are lacking. This cross-sectional epidemiological study evaluated health …

Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial

A D'Urzo, GT Ferguson, JA van Noord, K Hirata… - Respiratory …, 2011 - Springer
Background NVA237 is a once-daily dry-powder formulation of the long-acting muscarinic
antagonist glycopyrronium bromide in development for the treatment of chronic obstructive …